Your browser doesn't support javascript.
loading
The anti-diabetic effects of GLP-1-gastrin dual agonist ZP3022 in ZDF rats.
Skarbaliene, Jolanta; Secher, Thomas; Jelsing, Jacob; Neerup, Trine S R; Billestrup, Nils; Fosgerau, Keld.
Afiliação
  • Skarbaliene J; Research and Development, Zealand Pharma A/S, Glostrup, Denmark. Electronic address: jsk@zealandpharma.com.
  • Secher T; Gubra ApS, Hørsholm, Denmark.
  • Jelsing J; Gubra ApS, Hørsholm, Denmark.
  • Ansarullah; The Sanford Project, Children Health Research Center, Sanford Research/USD, Sioux Falls, SD, United States.
  • Neerup TS; Research and Development, Zealand Pharma A/S, Glostrup, Denmark.
  • Billestrup N; Department of Biomedical Sciences, University of Copenhagen, Denmark.
  • Fosgerau K; Research and Development, Zealand Pharma A/S, Glostrup, Denmark.
Peptides ; 69: 47-55, 2015 Jul.
Article em En | MEDLINE | ID: mdl-25849341

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Gastrinas / Diabetes Mellitus Tipo 2 / Peptídeo 1 Semelhante ao Glucagon Limite: Animals / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Gastrinas / Diabetes Mellitus Tipo 2 / Peptídeo 1 Semelhante ao Glucagon Limite: Animals / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article